{"DataElement":{"publicId":"3646391","version":"1","preferredName":"Laboratory Procedure Mitoses Per 50 High Power Fields Count Value","preferredDefinition":"Numeric representation of the mitoses count per 50 high power fields.","longName":"3646390v1.0:3646287v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3646390","version":"1","preferredName":"Laboratory Procedure Mitoses Per 50 High Power Fields Count","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._For each, generally denoting a ratio._A number with no fractional part, including the negative and positive numbers as well as zero.::50_The area visible under the maximum magnification power of the objective being used in microscopy._The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","longName":"2543047v1.0:3646388v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3646388","version":"1","preferredName":"Per Integer::50 High Power Field Mitotic Count","preferredDefinition":"For each, generally denoting a ratio.:A number with no fractional part, including the negative and positive numbers as well as zero.::50:The area visible under the maximum magnification power of the objective being used in microscopy.:The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","longName":"3646388v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"High Power Field","conceptCode":"C67274","definition":"The area visible under the maximum magnification power of the objective being used in microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D13D17ED-7B9D-36E2-E040-BB89AD434DA0","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-19","modifiedBy":"ONEDATA","dateModified":"2012-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D13D17ED-7BAE-36E2-E040-BB89AD434DA0","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TCGA Adrenocortical form and released per approval by T.Lichtenberg. mc 1/4/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3646287","version":"1","preferredName":"Mitotic Count Value","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._A numerical quantity measured or assigned or computed.","longName":"3646287v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3646286","version":"1","preferredName":"Mitotic Count Value","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.:A numerical quantity measured or assigned or computed.","longName":"C47864:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1399942-08D1-FF58-E040-BB89AD4341E1","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-19","modifiedBy":"ONEDATA","dateModified":"2012-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1399942-08E2-FF58-E040-BB89AD4341E1","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-19","modifiedBy":"COOPERM","dateModified":"2013-01-04","changeDescription":"Created for TCGA Adrenocortical form and released per approval by T.Lichtenberg. mc 1/4/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Mitoses per 50 High Powered F","type":"Preferred Question Text","description":"Mitoses per 50 High Powered Fields (HPF)","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D13D17ED-7BC6-36E2-E040-BB89AD434DA0","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-12-19","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for TCGA Adrenocortical form and released per approval by T.Lichtenberg. mc 1/4/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}